These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8508614)

  • 1. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
    van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW
    Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes.
    Ahrén B; Gutniak M
    Eur J Endocrinol; 1997 Dec; 137(6):643-9. PubMed ID: 9437230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM.
    Lindström T; Leckström A; Westermark P; Arnqvist HJ
    Diabet Med; 1997 Jun; 14(6):472-6. PubMed ID: 9212313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for the determination of islet amyloid polypeptide levels in plasma.
    van Hulst KL; Hackeng WH; Höppener JW; van Jaarsveld BC; Nieuwenhuis MG; Blankenstein MA; Lips CJ
    Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():165-70. PubMed ID: 8060096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
    Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
    Iki K; Pour PM
    J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism.
    Valdermarsson S; Leckström A; Westermark P; Bergenfelz A
    Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
    Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
    N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
    Tomita T
    Islets; 2011; 3(4):166-74. PubMed ID: 21633185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals.
    Westermark P; Wilander E; Westermark GT; Johnson KH
    Diabetologia; 1987 Nov; 30(11):887-92. PubMed ID: 3328723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to islet amyloid polypeptide in diabetes.
    Clark A; Yon SM; de Koning EJ; Holman RR
    Diabet Med; 1991; 8(7):668-73. PubMed ID: 1833120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postpartum evaluation of amylin secretion in gestational diabetes mellitus].
    Kinalski M; Sledziewski A; Telejko B; Mironczuk K; Kretowski A; Kinalska I
    Med Wieku Rozwoj; 2002; 6(1):75-80. PubMed ID: 12177515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.